Daré Bioscience Investor Relations Material
Latest events
Q1 2025
Daré Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Daré Bioscience Inc
Access all reports
Daré Bioscience Inc. is a biopharmaceutical company focused on developing and commercializing innovative products for women’s health. The company’s portfolio includes therapies aimed at addressing unmet needs in contraception, fertility, and sexual health. Daré’s products are designed to improve options for women by offering novel solutions in areas such as hormone-free contraception and treatments for female sexual disorders. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
DARE
Country
🇺🇸 United States